Zobrazeno 1 - 10
of 203
pro vyhledávání: '"L.A. Salako"'
Publikováno v:
Tropical Medicine & International Health. 3:177-183
The efficacy of chloroquine and chloroquine plus chloropheniramine, a histamine H1 receptor blocker which reverses chloroquine insensitivity in Plasmodium falciparum in vitro, was studied in 96 children with acute symptomatic uncomplicated falciparum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b395f03bda5421958a10b0b8ed5eb69e
https://doi.org/10.1046/j.1365-3156.1998.00212.x
https://doi.org/10.1046/j.1365-3156.1998.00212.x
Autor:
Ayoade M.J. Oduola, A. Sowunmi, L.A. Salako, O.A.T. Ogundahunsi, Catherine O. Falade, Grace O. Gbotosho
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 91:63-67
Chlorpheniramine, a histamine H1 receptor antagonist, reverse chloroquine resistance in Plasmodium falciparum in vitro. However, the clinical significance of this remains unclear. We have evaluated the efficacy of chloroquine and a chloroquine-chlorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc2b77cb910268a1e8a175445c6edaf
https://doi.org/10.1016/s0035-9203(97)90399-0
https://doi.org/10.1016/s0035-9203(97)90399-0
Autor:
Abdulrazaq G. Habib, Isa S. Abubakar, Nicola Alder, L.A. Salako, Elijah N Sokomba, Ed Juszczak, R. David G. Theakston, Abdulsalam Nasidi, John Garnvwa, Nandul Durfa, Saidu B. Abubakar, David A. Warrell, Solomon Larnyang, Peter Ofemile Yusuf
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 4, Iss 7, p e767 (2010)
PLoS Neglected Tropical Diseases, Vol 4, Iss 7, p e767 (2010)
Background In West Africa, envenoming by saw-scaled or carpet vipers (Echis ocellatus) causes great morbidity and mortality, but there is a crisis in supply of effective and affordable antivenom (ISRCTN01257358). Methods In a randomised, double-blind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fbf564a29bd393017cbad0ecda06112
http://europepmc.org/articles/PMC2910709
http://europepmc.org/articles/PMC2910709
Autor:
A. Sowunmi, L.A. Salako
Publikováno v:
Annals of Tropical Medicine & Parasitology. 86:1-8
A parallel group-randomized comparison of the therapeutic efficacy of chloroquine (CQ), amodiaquine (AM), quinine (QN), sulphadoxine-pyrimethamine (S-P), mefloquine 15 mg kg-1 (M15) and mefloquine 25 mg kg-1 (M25) in acute symptomatic uncomplicated f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cffcc1268e65bf09d502f1d0c0fd1b74
https://doi.org/10.1080/00034983.1992.11812625
https://doi.org/10.1080/00034983.1992.11812625
Publikováno v:
Annals of Tropical Paediatrics. 12:155-158
Hyperparasitaemia as an indicator of severity or poor prognosis in falciparum malaria and response to oral antimalarial therapy were evaluated in an outpatient study of 77 consecutive African children from an endemic area. At presentation, clinical i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb21b61f309c16ecdd406c01cf09cbe2
https://doi.org/10.1080/02724936.1992.11747561
https://doi.org/10.1080/02724936.1992.11747561
Autor:
Risquat A. Adio, U. Dickschat, R. Reber-Liske, D Stürchler, L.A. Salako, M.-L. Mittelholzer, A. Sowunmi, O. Walker
Publikováno v:
Annals of Tropical Medicine & Parasitology. 86:575-581
From July 1987 to June 1988 a randomized, double-blind, comparative placebo-controlled field trial was conducted in a group of villages near Ibadan, Nigeria. The aim of the study was to assess the suppressive tolerability and efficacy of four antimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff1c07197674260993224b434160772
https://doi.org/10.1080/00034983.1992.11812712
https://doi.org/10.1080/00034983.1992.11812712
Autor:
Edmund Juszczak, Nicola Alder, Gavin D. Laing, Peter Ofemile Yusuf, Abdulrazaq G. Habib, Saidu B. Abubakar, David A. Warrell, L.A. Salako, A. Nasidi, Nandul Durfa, J. Garnvwa, Elijah N Sokomba, R.D.G. Theakston, Isa S. Abubakar, S. Larnyang
Publikováno v:
Toxicon : official journal of the International Society on Toxinology. 55(4)
The aim of this study was to identify candidate antivenoms with specific activity against the venom of the saw-scaled or carpet viper (Echis ocellatus) in northern Nigeria, where bites by this species cause great morbidity and mortality but where eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d66e8fae2613d3eef1bc54ff80fb70c
https://pubmed.ncbi.nlm.nih.gov/20171240
https://pubmed.ncbi.nlm.nih.gov/20171240
Autor:
H O Dada-Adegbola, Ayoade M Oduola, Mailis Virtanen, Philip Hunt, Catherine O. Falade, L.A. Salako, Adegoke G Falade, Patricia Ibarra de Palacios, O. O. Ogunkunle
Publikováno v:
Malaria Journal, Vol 7, Iss 1, p 246 (2008)
Malaria Journal
Malaria Journal
Background The six-dose regimen of artemether-lumefantrine (AL) is now considered the gold standard for the treatment of uncomplicated Plasmodium falciparum malaria. There are few reports evaluating co-artemether in very young Nigerian infants and ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6e05da43acdd2f438c1d2eddeae951
http://www.malariajournal.com/content/7/1/246
http://www.malariajournal.com/content/7/1/246
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 84:761-764
One hundred and thirteen children with symptomatic uncomplicated falciparum malaria were treated with either chloroquine 25 mg/kg body weight over 3 d (51 subjects) or mefloquine 25 mg/kg body weight single dose (62 subjects). The cure rate in the ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e04a2d9816ac76eabcfbd3e82d95b8
https://doi.org/10.1016/0035-9203(90)90067-o
https://doi.org/10.1016/0035-9203(90)90067-o
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 84:626-629
Thirteen patients with acute symptomatic uncomplicated falciparum malaria were enrolled in an open, randomized, phase 2, dose-finding clinical trial of a fixed dosage combination of quinine, quinidine and cinchonine (LA40221, Sanofi Recherche, France
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9dd2dc629ca9e7714bc65ec62b262b
https://doi.org/10.1016/0035-9203(90)90127-z
https://doi.org/10.1016/0035-9203(90)90127-z